← Leaderboards
Wei R. Chen
University Of Central Oklahoma
$2,846,133
Attributed
$3,829,386
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $535.6K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,829,386 · 3
By mechanism
R01$3,479,790 · 2
R21$349,596 · 1
Top collaborators
- Min Li4 shared
Others in their field
Top investigators on “Lasers”
- Albert Lazzarini · California Institute Of Technology$322,785,989
- David H Reitze · University Of Florida$319,789,440
- Peter K Fritschel · California Institute Of Technology$78,820,000
- David H Shoemaker · California Institute Of Technology$68,727,967
- Eric Baer · Case Western Reserve University$37,136,000
- Philip J Reid · University Of Washington$36,331,320
Research focus
LasersMonitorThermometryImmunityCancer TherapyDisseminated Malignant NeoplasmNeoplastic CellTemperatureDoseTumorImmunologic AdjuvantsMagnetic ResonanceAnimalsResponseGlycated ChitosanImmune ResponseImmune Checkpoint InhibitorImmune SystemImmunotherapyMalignant Breast NeoplasmModalityFoundationsImmunologicsConventional Therapy
Grant awards (11)
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors$489,114
R01 · FY2025 · CA · contact PI
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors$465,002
R01 · FY2024 · CA · contact PI
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors$476,752
R01 · FY2023 · CA · contact PI
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors$535,638
R01 · FY2022 · CA · contact PI
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers$354,563
R01 · FY2021 · CA · contact PI
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers$342,355
R01 · FY2020 · CA · contact PI
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers$266,624
R01 · FY2019 · CA · contact PI
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers$274,871
R01 · FY2018 · CA · contact PI
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers$274,871
R01 · FY2017 · CA · contact PI
A Novel Multifunctional Bionanoprobe-Based Phototherapy for Metastatic Cancers$187,298
R21 · FY2014 · EB · contact PI
A Novel Multifunctional Bionanoprobe-Based Phototherapy for Metastatic Cancers$162,298
R21 · FY2013 · EB · contact PI